跳轉至內容
Merck
全部照片(1)

重要文件

檢視所有文件

47674

Sigma-Aldrich

FFmoc-N-三苯甲基-L-谷氨酰胺

≥98.0% (HPLC), for peptide synthesis

同義詞:

Nα-Fmoc-Nδ-三苯甲基-L-谷氨酰胺

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C39H34N2O5
CAS號碼:
132327-80-1
分子量：:
610.70
Beilstein:
4343953
MDL號碼:
MFCD00077056
分類程式碼代碼:
12352209
eCl@ss:
32160406
PubChem物質ID:
57651077
NACRES:
NA.26

產品名稱

FFmoc-N-三苯甲基-L-谷氨酰胺, ≥98.0% (HPLC)

化驗

≥98.0% (HPLC)

形狀

powder

光學活性

[α]/D -14.0±1.5°, c = 1% in DMF

反應適用性

reaction type: Fmoc solid-phase peptide synthesis

應用

peptide synthesis

官能基

Fmoc

儲存溫度

2-8°C

SMILES 字串

OC(=O)[C@H](CCC(=O)NC(c1ccccc1)(c2ccccc2)c3ccccc3)NC(=O)OCC4c5ccccc5-c6ccccc46

InChI

1S/C39H34N2O5/c42-36(41-39(27-14-4-1-5-15-27,28-16-6-2-7-17-28)29-18-8-3-9-19-29)25-24-35(37(43)44)40-38(45)46-26-34-32-22-12-10-20-30(32)31-21-11-13-23-33(31)34/h1-23,34-35H,24-26H2,(H,40,45)(H,41,42)(H,43,44)/t35-/m0/s1

InChI 密鑰

WDGICUODAOGOMO-DHUJRADRSA-N

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

Fmoc-Gln(Trt)-OH 也称 Nα-Fmoc-Nδ-三苯甲基-L-谷氨酰胺，它是 Fmoc 保护的氨基酸衍生物，可用作合成肽的试剂。 由于谷氨酰胺受到三苯甲基保护，因此可以防止在反应中出现不需要的取代产物。

應用

Fmoc-Gln(Trt)-OH可用作Fmoc 固相肽合成的原料，用于合成fellutamide B 和 fellutamide B的N-辛酰基类似物。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 1

個人防護裝備

Eyeshields, Gloves, type N95 (US)

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number
BCCG2426
BCCF4932
BCCC8888
BCCB9522
BCBZ1861

未看到正確版本？

如果您需要一個特定的版本，您可以透過批號來尋找特定憑證。

搜尋 COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Cathleen Jendrny et al.
Chembiochem : a European journal of chemical biology, 17(8), 719-726 (2015-11-18)
Serpin proteins irreversibly inhibit serine proteases, but only a small part of the serpin reactive-center loop (RCL) is responsible for the initial protein-protein interaction (PPI). To develop peptidic protease inhibitors, kallikrein-related peptidases 7 (KLK7) and 5 (KLK5) were chosen. Firstly
Marcus Pickhardt et al.
Current Alzheimer research, 14(7), 742-752 (2017-02-06)
Anti-aggregation drugs play an important role in therapeutic approaches for Alzheimer's disease. We have previously developed a number of compounds that are able to inhibit the pathological aggregation of Tau protein. One common obstacle to application is the limited penetration
Fatemeh Zabihi et al.
Journal of controlled release : official journal of the Controlled Release Society, 242, 35-41 (2016-07-30)
Nanogels offer many unique features rendering them as very attractive candidates for drug delivery. However, for their applications the loading capacity and specific encapsulation, in particular for hydrophobic drugs, in a complex media are two critical factors. In this work
Hong Cheng et al.
Macromolecular bioscience, 19(4), e1800410-e1800410 (2018-12-24)
In this paper, a self-delivery chimeric peptide PpIX-PEG8 -KVPRNQDWL is designed for photodynamic therapy (PDT) amplified immunotherapy against malignant melanoma. After self-assembly into nanoparticles (designated as PPMA), this self-delivery system shows high drug loading rate, good dispersion, and stability as
Zdenek Kukacka et al.
ChemMedChem, 13(9), 909-915 (2018-02-24)
α-Galactosidase (αGal) is a lysosomal enzyme that hydrolyses the terminal α-galactosyl moiety from glycosphingolipids. Mutations in the encoding genes for αGal lead to defective or misfolded enzyme, which results in substrate accumulation and subsequent organ dysfunction. The metabolic disease caused
查看所有相關論文

文章

Natural Amino Acid Building Blocks for Peptide Synthesis

With a growing peptide drug market the fast, reliable and uncomplicated synthesis of peptides is of paramount importance.

Natural Amino Acid Building Blocks for Peptide Synthesis

With a growing peptide drug market the fast, reliable and uncomplicated synthesis of peptides is of paramount importance.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務